Core Viewpoint - Universal Health Services, Inc. (UHS) demonstrates strong financial performance and growth potential, leading UBS to maintain a "Buy" rating and raise its price target from $280 to $302 [1][6]. Financial Performance - UHS reported a 53% year-over-year increase in earnings per share (EPS) for Q3, reaching $5.69, which exceeded the Zacks Consensus Estimate by 22% [2][6]. - The company's revenues rose by 13.4% to $4.5 billion in Q3, surpassing the consensus mark by 4.2% [3]. - Adjusted EBITDA increased by 27.4%, reaching $670.6 million, supported by higher admissions and patient days [3]. Market Position - Despite challenges from elevated operating costs, UHS's strong top-line growth and improved segmental revenues highlight its robust market position and operational efficiency [4]. - The company has consistently outperformed consensus EPS estimates over the past four quarters, reinforcing its reputation as a reliable performer in the healthcare industry [4]. Stock Performance - UHS's current stock price is $224.54, reflecting a 2.38% increase, with a 52-week high of $226.72 and a low of $152.33 [5]. - The market capitalization of UHS stands at approximately $14.29 billion, with a trading volume of 76,863 shares [5].